Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Circulatory Disease | Research

Cause-specific excess mortality after hip fracture: the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS)

Authors: Kristin Holvik, Christian Lycke Ellingsen, Siri Marie Solbakken, Trine Elisabeth Finnes, Ove Talsnes, Guri Grimnes, Grethe S. Tell, Anne-Johanne Søgaard, Haakon E. Meyer

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Background

Information on cause of death may help appraise the degree to which the high excess mortality after hip fracture reflects pre-existing comorbidities or the injury itself. We aimed to describe causes of death and cause-specific excess mortality through the first year after hip fracture.

Methods

For studying the distribution of causes of death by time after hip fracture, we calculated age-adjusted cause-specific mortality at 1, 3, 6 and 12 months in patients hospitalized with hip fracture in Norway 1999–2016. Underlying causes of death were obtained from the Norwegian Cause of Death Registry and grouped by the European Shortlist for Causes of Death. For estimating excess mortality, we performed flexible parametric survival analyses comparing mortality hazard in patients with hip fracture (2002–2017) with that of age- and sex matched controls drawn from the Population and Housing Census 2001.

Results

Of 146,132 Norwegians with a first hip fracture, a total of 35,498 (24.3%) died within one year. By 30 days post-fracture, external causes (mainly the fall causing the fracture) were the underlying cause for 53.8% of deaths, followed by circulatory diseases (19.8%), neoplasms (9.4%), respiratory diseases (5.7%), mental and behavioural disorders (2.0%) and diseases of the nervous system (1.3%). By one-year post-fracture, external causes and circulatory diseases together accounted for approximately half of deaths (26.1% and 27.0%, respectively). In the period 2002–2017, cause-specific one-year relative mortality hazard in hip fracture patients vs. population controls ranged from 1.5 for circulatory diseases to 2.5 for diseases of the nervous system in women, and correspondingly, from 2.4 to 5.3 in men.

Conclusions

Hip fractures entail high excess mortality from all major causes of death. However, the traumatic injury of a hip fracture is the most frequently reported underlying cause of death among older patients who survive less than one year after their fracture.
Literature
1.
go back to reference Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, Boonen S. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152(6):380–90.CrossRefPubMedPubMedCentral Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, Boonen S. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152(6):380–90.CrossRefPubMedPubMedCentral
2.
go back to reference Katsoulis M, Benetou V, Karapetyan T, Feskanich D, Grodstein F, Pettersson-Kymmer U, Eriksson S, Wilsgaard T, Jørgensen L, Ahmed LA, et al. Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project. J Intern Med. 2017;281(3):300–31.CrossRefPubMed Katsoulis M, Benetou V, Karapetyan T, Feskanich D, Grodstein F, Pettersson-Kymmer U, Eriksson S, Wilsgaard T, Jørgensen L, Ahmed LA, et al. Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project. J Intern Med. 2017;281(3):300–31.CrossRefPubMed
3.
go back to reference Omsland TK, Emaus N, Tell GS, Magnus JH, Ahmed LA, Holvik K, Center J, Forsmo S, Gjesdal CG, Schei B, et al. Mortality following the first hip fracture in Norwegian women and men (1999-2008). A NOREPOS study. Bone. 2014;63c:81–6.CrossRef Omsland TK, Emaus N, Tell GS, Magnus JH, Ahmed LA, Holvik K, Center J, Forsmo S, Gjesdal CG, Schei B, et al. Mortality following the first hip fracture in Norwegian women and men (1999-2008). A NOREPOS study. Bone. 2014;63c:81–6.CrossRef
4.
5.
go back to reference Søgaard AJ, Meyer HE, Emaus N, Grimnes G, Gjesdal CG, Forsmo S, Schei B, Tell GS. Cohort profile: Norwegian Epidemiologic Osteoporosis Studies (NOREPOS). Scand J Public Health. 2014;42(8):804–13.CrossRefPubMed Søgaard AJ, Meyer HE, Emaus N, Grimnes G, Gjesdal CG, Forsmo S, Schei B, Tell GS. Cohort profile: Norwegian Epidemiologic Osteoporosis Studies (NOREPOS). Scand J Public Health. 2014;42(8):804–13.CrossRefPubMed
6.
go back to reference Omsland TK, Holvik K, Meyer HE, Center JR, Emaus N, Tell GS, Schei B, Tverdal A, Gjesdal CG, Grimnes G, et al. Hip fractures in Norway 1999–2008: time trends in total incidence and second hip fracture rates: a NOREPOS study. Eur J Epidemiol. 2012;27(10):807–14.CrossRefPubMed Omsland TK, Holvik K, Meyer HE, Center JR, Emaus N, Tell GS, Schei B, Tverdal A, Gjesdal CG, Grimnes G, et al. Hip fractures in Norway 1999–2008: time trends in total incidence and second hip fracture rates: a NOREPOS study. Eur J Epidemiol. 2012;27(10):807–14.CrossRefPubMed
7.
go back to reference Søgaard AJ, Holvik K, Meyer HE, Tell GS, Gjesdal CG, Emaus N, Grimnes G, Schei B, Forsmo S, Omsland TK. Continued decline in hip fracture incidence in Norway: a NOREPOS study. Osteoporos Int. 2016;27(7):2217–22.CrossRefPubMed Søgaard AJ, Holvik K, Meyer HE, Tell GS, Gjesdal CG, Emaus N, Grimnes G, Schei B, Forsmo S, Omsland TK. Continued decline in hip fracture incidence in Norway: a NOREPOS study. Osteoporos Int. 2016;27(7):2217–22.CrossRefPubMed
8.
go back to reference Kjeldgaard HK, Meyer HE, O’Flaherty M, Apalset EM, Dahl C, Emaus N, Fenstad AM, Furnes O, Gjertsen JE, Hoff M, et al. Impact of total hip replacements on the incidence of hip fractures in Norway during 1999–2019. A NOREPOS study. J Bone Miner Res. 2022;37(10):1936–43.CrossRefPubMed Kjeldgaard HK, Meyer HE, O’Flaherty M, Apalset EM, Dahl C, Emaus N, Fenstad AM, Furnes O, Gjertsen JE, Hoff M, et al. Impact of total hip replacements on the incidence of hip fractures in Norway during 1999–2019. A NOREPOS study. J Bone Miner Res. 2022;37(10):1936–43.CrossRefPubMed
11.
go back to reference Pedersen AG, Ellingsen CL. Data quality in the Causes of Death Registry. J Norw Med Assoc (Tidsskr Nor Laegeforen). 2015;135(8):768–70.CrossRef Pedersen AG, Ellingsen CL. Data quality in the Causes of Death Registry. J Norw Med Assoc (Tidsskr Nor Laegeforen). 2015;135(8):768–70.CrossRef
13.
go back to reference Johansson LA, Westerling R. Comparing hospital discharge records with death certificates: can the differences be explained? J Epidemiol Community Health. 2002;56(4):301–8.CrossRefPubMedPubMedCentral Johansson LA, Westerling R. Comparing hospital discharge records with death certificates: can the differences be explained? J Epidemiol Community Health. 2002;56(4):301–8.CrossRefPubMedPubMedCentral
14.
go back to reference Lu TH. Using ACME (Automatic Classification of Medical Entry) software to monitor and improve the quality of cause of death statistics. J Epidemiol Community Health. 2003;57(6):470–1.CrossRefPubMedPubMedCentral Lu TH. Using ACME (Automatic Classification of Medical Entry) software to monitor and improve the quality of cause of death statistics. J Epidemiol Community Health. 2003;57(6):470–1.CrossRefPubMedPubMedCentral
15.
go back to reference Lu TH, Tsau SM, Wu TC. The Automated Classification of Medical Entities (ACME) system objectively assessed the appropriateness of underlying cause-of-death certification and assignment. J Clin Epidemiol. 2005;58(12):1277–81.CrossRefPubMed Lu TH, Tsau SM, Wu TC. The Automated Classification of Medical Entities (ACME) system objectively assessed the appropriateness of underlying cause-of-death certification and assignment. J Clin Epidemiol. 2005;58(12):1277–81.CrossRefPubMed
19.
go back to reference StataCorp. Stata statistical software: release 17. College Station: StataCorp LLC; 2021. StataCorp. Stata statistical software: release 17. College Station: StataCorp LLC; 2021.
20.
go back to reference Ohneberg K, Beyersmann J, Schumacher M. Exposure density sampling: dynamic matching with respect to a time-dependent exposure. Stat Med. 2019;38(22):4390–403.CrossRefPubMed Ohneberg K, Beyersmann J, Schumacher M. Exposure density sampling: dynamic matching with respect to a time-dependent exposure. Stat Med. 2019;38(22):4390–403.CrossRefPubMed
21.
go back to reference Ohneberg K. Sampling Designs for Complex Time-to-Event Data in Clinical and Epidemiological Studies. Germany: Albert-Ludwigs-Universität Freiburg; 2019. Ohneberg K. Sampling Designs for Complex Time-to-Event Data in Clinical and Epidemiological Studies. Germany: Albert-Ludwigs-Universität Freiburg; 2019.
23.
go back to reference Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515–26.CrossRef Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515–26.CrossRef
24.
go back to reference Royston P, Lambert PC. Flexible parametric survival analysis using Stata: beyond the Cox Model. College Station: Stata Press; 2011. Royston P, Lambert PC. Flexible parametric survival analysis using Stata: beyond the Cox Model. College Station: Stata Press; 2011.
25.
go back to reference Sjölander A, Greenland S. Ignoring the matching variables in cohort studies - when is it valid and why? Stat Med. 2013;32(27):4696–708.CrossRefPubMed Sjölander A, Greenland S. Ignoring the matching variables in cohort studies - when is it valid and why? Stat Med. 2013;32(27):4696–708.CrossRefPubMed
26.
go back to reference Holvik K, Hjellvik V, Karlstad Ø, Gunnes N, Hoff M, Tell GS, Meyer HE. Contribution of an extensive medication-based comorbidity index (Rx-Risk) in explaining the excess mortality after hip fracture in older Norwegians: a NOREPOS cohort study. BMJ Open. 2022;12(5): e057823.CrossRefPubMedPubMedCentral Holvik K, Hjellvik V, Karlstad Ø, Gunnes N, Hoff M, Tell GS, Meyer HE. Contribution of an extensive medication-based comorbidity index (Rx-Risk) in explaining the excess mortality after hip fracture in older Norwegians: a NOREPOS cohort study. BMJ Open. 2022;12(5): e057823.CrossRefPubMedPubMedCentral
28.
go back to reference Vestergaard P, Rejnmark L, Mosekilde L. Has mortality after a hip fracture increased? J A, Geriatr Soc. 2007;55(11):1720–6.CrossRef Vestergaard P, Rejnmark L, Mosekilde L. Has mortality after a hip fracture increased? J A, Geriatr Soc. 2007;55(11):1720–6.CrossRef
29.
go back to reference Rohold CK, Lauritzen JB, Jørgensen HL. Causes of death among 93.637 hip fracture patients- data based on the Danish national registry of causes of death. Eur J Trauma Emerg Surg. 2022;48(3):1861–70.CrossRefPubMed Rohold CK, Lauritzen JB, Jørgensen HL. Causes of death among 93.637 hip fracture patients- data based on the Danish national registry of causes of death. Eur J Trauma Emerg Surg. 2022;48(3):1861–70.CrossRefPubMed
30.
go back to reference von Friesendorff M, McGuigan FE, Wizert A, Rogmark C, Holmberg AH, Woolf AD, Åkesson K. Hip fracture, mortality risk, and cause of death over two decades. Osteoporos Int. 2016;27(10):2945–53.CrossRef von Friesendorff M, McGuigan FE, Wizert A, Rogmark C, Holmberg AH, Woolf AD, Åkesson K. Hip fracture, mortality risk, and cause of death over two decades. Osteoporos Int. 2016;27(10):2945–53.CrossRef
31.
go back to reference Panula J, Pihlajamäki H, Mattila VM, Jaatinen P, Vahlberg T, Aarnio P, Kivelä SL. Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study. BMC Musculoskelet Disord. 2011;12:105.CrossRefPubMedPubMedCentral Panula J, Pihlajamäki H, Mattila VM, Jaatinen P, Vahlberg T, Aarnio P, Kivelä SL. Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study. BMC Musculoskelet Disord. 2011;12:105.CrossRefPubMedPubMedCentral
32.
go back to reference Choi HG, Lee YB, Rhyu SH, Kwon BC, Lee JK. Mortality and cause of death postoperatively in patients with a hip fracture: a national cohort longitudinal follow-up study. Bone Joint J. 2018;100-B(4):436–42.CrossRefPubMed Choi HG, Lee YB, Rhyu SH, Kwon BC, Lee JK. Mortality and cause of death postoperatively in patients with a hip fracture: a national cohort longitudinal follow-up study. Bone Joint J. 2018;100-B(4):436–42.CrossRefPubMed
33.
go back to reference Naghavi M, Makela S, Foreman K, O’Brien J, Pourmalek F, Lozano R. Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr. 2010;8:9.CrossRefPubMedPubMedCentral Naghavi M, Makela S, Foreman K, O’Brien J, Pourmalek F, Lozano R. Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr. 2010;8:9.CrossRefPubMedPubMedCentral
34.
go back to reference Naghavi M, Richards N, Chowdhury H, Eynstone-Hinkins J, Franca E, Hegnauer M, Khosravi A, Moran L, Mikkelsen L, Lopez AD. Improving the quality of cause of death data for public health policy: are all “garbage” codes equally problematic? BMC Med. 2020;18(1):55.CrossRefPubMedPubMedCentral Naghavi M, Richards N, Chowdhury H, Eynstone-Hinkins J, Franca E, Hegnauer M, Khosravi A, Moran L, Mikkelsen L, Lopez AD. Improving the quality of cause of death data for public health policy: are all “garbage” codes equally problematic? BMC Med. 2020;18(1):55.CrossRefPubMedPubMedCentral
35.
go back to reference Mikkelson L, Richards N, Lopez AD. Redefining ‘garbage codes’ for public health policy: Report on the expert group meeting, 27–28 February 2017. Civil Registration and Vital Statistics (CRVS) best-practice and advocacy. Melbourne: University of Melbourne; 2019. Mikkelson L, Richards N, Lopez AD. Redefining ‘garbage codes’ for public health policy: Report on the expert group meeting, 27–28 February 2017. Civil Registration and Vital Statistics (CRVS) best-practice and advocacy. Melbourne: University of Melbourne; 2019.
36.
go back to reference Ellingsen CL, Alfsen GC, Ebbing M, Pedersen AG, Sulo G, Vollset SE, Braut GS. Garbage codes in the Norwegian cause of death registry 1996–2019. BMC Public Health. 2022;22(1):1301.CrossRefPubMedPubMedCentral Ellingsen CL, Alfsen GC, Ebbing M, Pedersen AG, Sulo G, Vollset SE, Braut GS. Garbage codes in the Norwegian cause of death registry 1996–2019. BMC Public Health. 2022;22(1):1301.CrossRefPubMedPubMedCentral
37.
go back to reference Ellingsen CL, Ebbing M, Alfsen GC, Vollset SE. Injury death certificates without specification of the circumstances leading to the fatal injury - the Norwegian cause of death registry 2005–2014. Popul Health Metr. 2018;16(1):20.CrossRefPubMedPubMedCentral Ellingsen CL, Ebbing M, Alfsen GC, Vollset SE. Injury death certificates without specification of the circumstances leading to the fatal injury - the Norwegian cause of death registry 2005–2014. Popul Health Metr. 2018;16(1):20.CrossRefPubMedPubMedCentral
Metadata
Title
Cause-specific excess mortality after hip fracture: the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS)
Authors
Kristin Holvik
Christian Lycke Ellingsen
Siri Marie Solbakken
Trine Elisabeth Finnes
Ove Talsnes
Guri Grimnes
Grethe S. Tell
Anne-Johanne Søgaard
Haakon E. Meyer
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-03910-5

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine